Alex A. Petrakian, M.D., F.A.C.C.

Address
115 W. Fifth Street
Tyler, TX 75703

Telephone: (903) 595-2283
Fax: (903) 597-2238

Private Practice

• 2000-Present: Cardiovascular Associates of East Texas, P.A., Tyler, Texas

Education

• 1971-1986: College Louise Wegmann Beirut, Lebanon, French Baccalaureate with Honors

Academic Degrees

• 1986-1989: American University of Beirut Beirut, Lebanon, Bachelor of Sciences in Biology with distinction
• 1989-1993: American University of Beirut Beirut, Lebanon, Doctor of Medicine

Post Graduate Training

Internal Medicine Residency

• 1993-1996: Baylor College of Medicine Houston, TX

Cardiology Fellowship

• 1996-1999: Baylor College of Medicine Houston, TX

Cardiac Electrophysiology Fellowship

• 1999-2000: Baylor College of Medicine Houston, TX

Licensure and Certification

• 2001: Certification Board for Nuclear Cardiology
• 1997-Present: Texas State Board of Medical Examiners
• 2000: American Board of Internal Medicine - Cardiac Electrophysiology
• 1999: American Board of Internal Medicine - Cardiovascular Diseases
• 1997: American Board of Internal Medicine
• 1993: Education Commission for Foreign Medical Graduates (ECFMG)

Hospital Appointments

• 2000-Present: Acting Staff - Trinity Mother Frances Hospital, Tyler, Texas
• 2000-Present: Acting Staff - East Texas Medical Center Hospital, Tyler, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Quitman, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Crockett, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Mount Vernon, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Pittsburg, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Jacksonville, Texas
• 2000-Present: Consulting - East Texas Medical Center Hospital, Athens, Texas
• 2000-Present: Consulting - Laird Memorial Hospital, Kilgore, Texas

Professional Societies and Other Memberships

• Fellow, American College of Cardiology
• Diplomate of the American Board of Internal Medicine
• Diplomate of the American Board of Internal Medicine-Cardiology
• Diplomate of the American Board of Internal Medicine-Cardiac Electrophysiolgy

• Investigator-MAVRIC-- Marquis/Maximo VR IC D Programming Practices Registry
• Investigator- MASTER-- Microvolt T Wave A lternan S Testing for Risk Stratification of Post MI Patients
• Investigator - WAVE -World wide application study of Marquis VR enhancements. A global prospective, non-randomized, multicenter trial that focuses on the wavelet dynamic discrimination criterion by use of the Marquis VR model 7230 implantable cardioverter defibrillator (ICD).
• Investigator - VAST - Ventricular arrhythmia suppression trial. A randomized, single-blinded, crossover, comparative trial of the rate smoothing feature. Of Guidant Prism and Prism II Automatic implantable cardio defibrillator.
• Participant - ALIVE - The Azimilide Post - infarct Survival Evaluation
• Participant - PURSUIT - Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
• Participant - AFFIRM - Atrial Fibrillation Follow-up Investigation of Rhythm Management
• Co-Investigator-ACUITY Trial- A randomized comparison of Angiomax (bivalirudin) versus Lovenox/Clexane (enoxaparin) in patients undergoing early invasive management for acute coronary syndrome without ST- segment elevation.
• Co-Investigator - AWARE - Analysis of a New AT/AF Detection Algorithm in Patients with Atrial Arrhythmias.
• Co-Investigator - LESS - Lower Energy Safety Study
• Co-Investigator - GUSTO IV AMI (Protocol CO116T31): A Phase III, randomized, open-label trial evaluating the efficacy and safety of. ReoPro T (ABCIXIMAB) in combination with reduced dose RetavaseT/Rapilysin T (Recombinant Plasminogen Activator, Reteplase, r-PA) for the treatment of acute myocardial infarction.
• Co-Investigator - AMISTAD II Trial (Phase III): A randomized, double-blind, placebo-controlled, multicenter trial to evaluate the efficacy and safety of Adenosine (Pallacor, Adenosine Injection) as an adjunct to reperfusion therapy (Thrombolysis or Mechanical Reperfusion) in the treatment of acute anterolateral myocardial infarction.
• Co-Investigator - VALIANT Trial Phase III (VALsartan In Acute myocardial Infarction): A multinational, multicenter, double-blind, randomized, active controlled, parallel group study comparing the efficacy and safety of long-term treatment with Valsartan, Captopril and their combination in high risk patients after myocardial infarction.
• Co-Investigator - VALIANT REGISTRY SUBSTUDY : VALIANT Trial Phase III (VALsartan In Acute myocardial iNfarcTion): A multinational, multicenter, double-blind, randomized, active controlled, parallel group study comparing the efficacy and safety of long-term treatment with Valsartan, Captopril and their combination in high risk patients after myocardial infarction.
• Co-Investigator - EPHESUS - IE-99-02-035, Clinical protocol for a double blind, randomized, placebo-controlled trial to evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction
• Co-Investigator - OCTAVE - CV137-120 Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril (OCTAVE) A Phase III, Randomized, Double Blind, Active Controlled Comparison of Omapatrilat and Enalapril in Subjects with newly Diagnosed or Established Hypertension
• Co-Investigator - REPLACE - TMC-BIV-00-01, Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events.
• Co-Investigator - REPLACE II - A Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events, Part 2: REPLACE-2 (TMC-BIV-01-03)
• Co-Investigator - SYNERGY- A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting with Acute Coronary Syndromes Aventix Pharmaceuticals Protocol Number ENO.GMA.301.IND# 31532
• Co-Investigator - A Double-Blind Comparison Of The Incidence Of Hypotension With Two Formulations Of Intravenous Amiodarone: Cordarone Ò I.V. vs Amiodarone Aqueous I.V. Injection - Protocol No. 058K1-312-US
• Co-Investigator - CRISP - A single Arm, Open label Study of Cervastatin (Baycol®) in Community based Patients with Hypercholesterolemia at risk for Cardiovascular Disease and patients with Cardiovascular Disease. To Monitor inflammatory markers
• Co-Investigator-INSPIRE :A Randomized, Prospective Multicenter Trial Evaluating The Role Of Adenosine Tc99m Sestamibi SinglepPhoton Emission Computed Tomography For Assessing Risk And Therapeutic Outcomes In Survivors Of Acute Myocardial Infarction.
• Co-Investigator - Otsuka Protocol 21-98-214-01 CASTLE " A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm, Study to Asses The Long-Term Effects of Pletal® (Cilostazol) Versus Placebo Administered Orally to Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease".
• Co-Investigator - AMIHOT - TherOx Aqueous Oxygen System - Acute Myocardial Infarction with Hyperoxemic Therapy "AMIHOT" Phase II clinical trial. A Randomized, Controlled, Multicenter Trial of Aqueous Oxygen Infusion for 90 Minutes Post-Primary PTCA/Stent Intervention in Acute Myocardial Infarction Patients.
• Co-Investigator - Extra Point. Protocol # S1710202. Cardiovascular Safety Study of Nicotine Transdermal System.

Publications

• Badruddin SM, Ahmad A, Petrakian AA, He ZX, Mahmarian JJ, Verani MS. Identification of left main and three vessel coronary artery disease by adenosine myocardial tomography. Proceedings of American College of Cardiology 46th Annual meeting, J Am Coll Cardiol 1997; 29 (SuppI A):262A
• Petrakian AA, Ahmad A, Badruddin SM, He ZX, Lakkis NM, Mahmarian JJ, Verani MS. Value of myocardial perfusion tomography in the assessment of post-stenting coronary restenosis. Proceedings of American College of Cardiology 46th Annual meeting, J Am Coll Cardiol 1997; 29 (Suppl A):228A
• Abmad A, Badruddin SM, Petrakian AA He ZX, Mahmarian JJ, Verani MS. Exercise SPECT versus exercise ECG testing for diagnosis of coronary artery disease in asymptomatic patients. Proceedings of American College of Cardiology 46 th Annual meeting, J Am Coll Cardiol 1997; 29 (Suppl A):261A
• Precipitating factors for accelerating ventricular tachycardia during anti­tachycardia pacing. Dennis W.X. Zhu, Huabin Sun, Alexandre A. Petrakian. Baylor College of Medicine. Houston, TX, USA.
• Abstract presented at the European Society of Cardiology jn Vienna, 1998
• Optimal coupling interval of antitachycardia pacing for termination of rapid ventricula tachycardia. Dennis W.X. Zhu, Huabin Sun, Alexandre A. Petrakian. Baylor College of Medicine, Houston, TX, USA.
• Abstract presented at tile European Society of Cardiology in Vienna, 1998
• Electrophysiological testing in patients undergoing ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Alexandre Petrakian, MD; William Spencer III, MD, Nasser Lakkis, MD, Huabin Sun, MD, Michael Gollob, MD, Donna Killip, RN. John Payne, MD
• Abstract presented at NASPE, 1999
• A comparison of T-wave alternans and electrophysiologic testing as a predictor of increased risk for sudden death in hypertrophic cardiomyopathy. Michael Gollob, MD, John Seger, MD, Jagaro Nattamma, MD, Alexandre Petrakian, Kiran Jayaram, MD, Donna Killip, RN, William Spencer III, MD, Baylor College of Medicine, Houston.
• Abstract presented at NASPE 2000.
• Assessment for ventricular arrhythmia substrate following Ethanol-induced septal infarction in hypertrophic obstructive cardiomyopathy. Michael Gollob, MD, John Seger, MD, Jagaro Nattamma, MD, Alexandre Petrakian, MD, Kiran Jayaram, MD, Donna Killip, RN, William Spencer III, MD, Baylor College of Medicine, Houston.
• Abstract presented at NASPE 2000.

Languages

• English
• French
• Arabic
• Medical Spanish

Awards received

• French Baccalaureate (1986) with Honors
• Dean's Honor list throughout College
• B.S, in Biology with distinction (1989)
• Dean's Honor list throughout medical school
• MD with distinction (1993)
• Van Reet Award (2000)